Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Announces Plans for IPO in the US



EL AVIV--Compugen announced plans to make an initial public offering in the US this year to support the expansion of its genetic R&D methods, according to a Dow Jones Newswire report. The company, which has identified more than 14,000 genes and gene sequences, has licensed its bioinformatics technologies to American Home ProductsWyeth-Ayerst division, Amgen, Bayer, Eli Lilly, Merck, Parke-Davis, and SmithKline Beecham. Compugen also recently announced the launch of an online research portal, Venture capital firms, including US Venture Partners, have invested $25 million in the company.

Part of Compugen’s gene discovery technology involves modeling where and how the first genes were found, something that the company contended is a more efficient method than other approaches. "It’s like oil exploration," said chairman Martin Gerstel in the news report. "All the other oil companies are hitting oil, but we’re creating a model based on how the first geyser was discovered."

Filed under

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.